Human angiotensin II

Drug Profile

Human angiotensin II

Alternative Names: (Asp1-Ile5) angiotensin II; Angiotensin II (human); Delivert; TY 10721

Latest Information Update: 11 Apr 2005

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Toa Eiyo
  • Developer Astellas Pharma; Toa Eiyo
  • Class Antineoplastics; Peptide fragments; Vasopressors
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Marketed Cancer

Most Recent Events

  • 11 Apr 2005 Yamanouchi has merged with Fujisawa to form Astellas Pharma
  • 28 Nov 2000 Profile reviewed but no significant changes made
  • 17 Jul 1998 TY 10721 is now called human angiotensin II
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top